Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys – Reuters

1. Sarepta says it won’t comply with FDA request to stop shipping gene therapy Elevidys  Reuters
2. FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths  fda.gov
3. Third death from a Sarepta gene therapy  biocentury.com
4. Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label  Sarepta Therapeutics
5. Exclusive: US FDA to request Sarepta to stop all shipments of gene therapy Elevidys, source says  Reuters

Continue Reading